Forget Garmin, Fitbit Charge 6 Fitness Tracker Hits Year's Lowest Price Right Before Memorial Day
If you've been eyeing a fitness tracker for some time to boost your routines and that seamlessly blends health insights with smart features, the Fitbit Charge 6 is the definitive choice for you. This high-end, classy device offers comprehensive health monitoring, built-in GPS, and integration with tons of Google apps, all wrapped in a stylish Porcelain design. Whether you're a fitness enthusiast or just starting your wellness journey, walking a few steps at a time, the Fitbit Charge 6 provides all the tools you might ever need to stay on track.
See at Amazon
For a limited time only, the Fitbit Charge 6 Fitness Tracker is available for just $119.45, down from its original price of $159.95. That's a 25% discount on one of Fitbit's most advanced and elegant trackers. This deal also includes a 6-month Fitbit Premium membership, offering personalized insights designed to help you in your journey, guided programs, and much more to elevate your health and fitness experience to the next level.
Tune in And Move to Your Beat
The Fitbit Charge 6 Fitness Tracker stands out from its competitors with its ability to monitor heart rate directly on compatible exercise equipment, which ensures the most accurate readings possible during either hard workouts or taking a quick, speedy walk. With over 40 different exercise modes, a built-in GPS, and daily readiness scores, it learns your routine and adapts to your fitness level, rhythm, and goals. This incredible device also tracks your sleep patterns, detects possible apneas, stress levels, and offers mindfulness sessions to support your overall well-being.
Designed for all-day wear and regular everyday use, the Fitbit Charge 6 Fitness Tracker boasts a solid 7-day battery life and is water-resistant, making it suitable for various activities and weather conditions. Its integration with several Google apps like Google Maps and Google Wallet adds a lot of convenience, allowing you to navigate and make payments freely, directly from your wrist. The included small and large bands ensure a comfortable fit for most wrist sizes.
At only $119.45, the Fitbit Charge 6 Fitness Tracker offers an exceptional value for those seeking a comprehensive fitness tracker without the need to break the bank. With a 25% discount from its original $159.95, and a 6-month Premium membership included, this deal provides both savings and enhanced features to support your health journey. Don't miss out on this incredible opportunity to invest in your well-being. Head to Amazon right now to take advantage of this amazing offer while it lasts.
See at Amazon
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
'Dead Girl' fights cancer and more, lives to share her story
May 30—Palliative nurse's notes, Aug. 2, 2019: "Participated in Hospice meeting with patient. Seth (spouse), mother, father, bedside RN. Andrea from Hospice was on speakerphone. Discussed philosophy of Hospice and services they provide. Advised that by accepting Hospice, patients have a terminal diagnosis with less then six months to live. Patient was surprised by this, stating she would not qualify. Gina had several questions regarding cancer diagnosis, stating, 'I don't think I am terminal' and unaware of staging/diagnosis .... Patient continues to repeat she is only 46 years old and would like to continue with a treatment as offered and hopefully start immunotherapy when able. Seth was in agreement and supportive." — Book excerpt WATERTOWN — Eugenia Mancini Horan opens the front door of her parent's home on outer Bradley Street to welcome a visitor, this writer, who tells her that from what he's read about her, she looks amazing. "Your reaction is much like when I go to a new doctor and they open the door and are like, 'I was expecting someone deader,'" she says, laughing. Eugenia ("Gina") has crawled, bled, begged, argued, rejoiced and has been mocked through the ravages of stage 4 cancer. It is simply amazing, a miracle some say, that she is alive and cancer free. She recounts her 2019 cancer journey in the self-published, "The Dead Girl's Guide to Terminal Cancer: A True Tale of Anxiety, Horror & Hope." It's been the number one best seller on Amazon's lung cancer category for several weeks. It's a hardbound 400 pages, the size of a college textbook and its emotional weight vastly outweighs its 2 pounds. Its cover features a deer-in-the headlights-like self-portrait of the author, who has won a slew of awards on the local arts scene for her oil paintings. Readers have called the book darkly humorous and poignant. With its various characters, tragic subplots of her youth, family dynamic and medical notes, its is also novelesque. For the gist of it, Gina summarizes it all in the book's afterward: "There are no heroes in this story, no saviors, no 'Good Doc With a Cure,' coming in for a last-minute save. There is only medical bias, cancer bias, and the notion that a girl who is afraid of the world can't fight like a rabid animal to stay alive." 'Let me live' "My whole story is fighting people to get them to let me live," Gina said in the room of her parents' home, where in 2019, a hospital bed was set up in front of a picture window and where many expected her to meet her demise while battling lung cancer which she said had spread to her trachea, bronchus and small bowel. "Somebody should be treated like they're dead when they are already dead." "It's such a scary diagnosis and we have put such faith in the white lab coat," said Seth, who helped his wife with the book. "I know because we did it. You will cling to anything you are told. That has been the most horrifying, duh! moment during this whole process: to have the curtain pulled back and it's like, these are just people. And people make mistakes. And every one of them made a mistake with her." "When putting out the book, you couldn't think about someone reading it because it's like, 'Here is every bad thing that ever happened to me and people treating me badly.' Would you like to read it? It's embarrassing," Gina said. "But I thought in it, there's got to be something that can help people: look for these red flags, don't just trust. I've been a cancer advocate for five years and now I have two enemies." One of those enemies, she said, is God. "Which sounds harsh, but people pray to God that he's going to cure cancer, so they become inactive." The second: "People implicitly trusting that their doctors have their best health in mind when they come up with cures. No doctor comes up with a cure. It's a list. It's, 'If you have this cancer, in this stage, this is what you get.'" Gina's "Dead Girl's Guide to Terminal Cancer" encapsulates one year, 2019, from when she was diagnosed to when she saved herself, thanks to her desperate pleas to try immunotherapy — specifically Keytruda — a type of immunotherapy that works by blocking a pathway to help prevent cancer cells from hiding. Immunotherapy uses a person's own immune system to fight cancer. Blood and a diagnosis Gina woke up on Christmas morning, 2018, at their home in North Syracuse and thought she had the flu or something. When she coughed, she noticed little flecks of blood on a tissue. As a smoker, she thought it could be normal. "But one night, it was abnormal," she said. "It was nose-bleed-like." She also experienced shortness of breath and a racing heartbeat. Gina said she has had symptoms of anxiety disorder since age 5 and was finally diagnosed with it at age 17. Considered disabled, she has Medicaid. At the medical appointment to address what she was coughing up, she said she was told, 'I think you just got yourself worked up with your anxiety.'" "And I'm like, 'That's powerful. I was torn because I wanted her to say it was nothing, and then when she said it was nothing, it was, 'I can't let it go. Can we run some blood work?' By the time we got home, the phone was ringing. I failed that blood work bad." What followed was a series of tests and scans that wreaked havoc on Gina's anxiety. She was diagnosed with non-small cell lung cancer in mid-February, 2019 at a Syracuse hospital, one of two hospitals in that city which treated her during her year-long ordeal. She doesn't name the hospitals in the book and requested the Syracuse hospitals not be named here. Radiology summary/Feb. 15, 2019: Impression: Right apical lobulated mass is seen. Right hilar lymph nodes are seen possibly exerting a mass effect on the right main bronchus. No pulmonary arterial embolus is identified." In the top portion of her uppermost lobe, there was an unusual mass. Also, some lymph nodes had grown large enough to restrict airflow through her right main bronchus. Surgery, which didn't make sense to Gina, was recommended. "How was taking out two lobes of my lungs — to remove the origin tumor that wasn't causing any issue — going to help with the mass that was actually threatening my life? Was this just busy work?" she writes in the book. A cancer diagnosis can bring thoughts of chemotherapy. That wasn't originally in the cards for Gina, a "card-carrying emetrophopbic." Emetophobia is the fear of vomiting and can be triggered just by seeing someone else being sick. As an alternative, Gina and Seth tried highly concentrated cannabis oil. Meanwhile, Gina's parents, Eugene and Clorise Mancini, urged her to come home to Watertown as her health declined. Gina and Seth moved there in May, 2019. "The drive there filled me with both anxiety and salvation," Gina wrote in the book. "Seth figured out how to get the oxygen compressor to work in the car." Gina could not walk to the front door, and it marked the first of hundreds of times that Seth would carry his wife. This year, on the sixth-year anniversary of her diagnosis, Gina, on Facebook, paid tribute to Seth, who she married in 2006: "My husband dropped everything when I got sick to be my caregiver. For five months everywhere I needed to go, he carried me because I couldn't walk. Bedpans? Did that. Suctioning out my trach? That too. Butt wiping? Yup, even that. Yet, most days, we still laughed because we were still us." Gina entered Walker Center for Cancer Care at Samaritan Medical Center, Watertown, for the first time on June 5, 2019, where she would stay as an inpatient for a week. She agreed to start chemotherapy on June 7, which continued weekly for five infusions before she had a hyperbaric breathing emergency and was taken by ambulance to an intensive care unit at a Syracuse hospital. She was at that ICU from July 17 to Aug. 9. "The chemo has failed me. I'm in a very bad place medically,"she wrote in a July 18, 2019 Facebook post. She was given a zero percent chance of survival. Hematology & Oncology Fellow notes July 31, 2019 "Patient has received palliative radiation therapy. 3 daily fractions in addition to one endobronchial brachytherapy ... Keytruda will not be given to an inpatient and patient needs to be more medically stable to be eligible for and tolerate further therapy." In the ICU, Gina was starving and her weight plummeted. A couple of photographs of a gaunt-looking Gina are on the book's back cover. "The reason I put those pictures there is because I was not sick because of cancer, but because of not being treated. It was, 'We are not going to feed the patient because the patient is dying. The patient is dying because she isn't being fed.' One of the reasons I wrote the book is because nobody around me understood the extent of the abuse that was happening, I know without a doubt, had I been able to talk, the entire story would have been different, because I would not have been docile about this happening." Excerpt from Psychological evaluation Aug. 1, 2019 "Patient clearly and persistently repeated ... that she wanted palliative care only rather than aggressive Rx intended to extend life because aggressive Rx was unlikely to work, and hospitalization was so unpleasant." "In retrospect, I had made an almost fatal error," Gina wrote. "I hadn't been willing to lie about my belief in my own death in order to get out." In other words, she said she had to be purposely deceptive to get into Hospice. On Aug. 9, 2019, Gina left the hospital for Hospice care at her North Syracuse home. It was a Friday. "The Hospice coordinator told us that someone would be back in 72 hours," Gina wrote. "She also told Seth I had about three days to live. What excruciating math." Gina received Hospice care for six days, after which she and Seth cut ties with it. Her goal was to return to the home she grew up in, in Watertown. She arrived Aug. 15. Seth carried her into the house. "I knew I was in very bad shape," Gina wrote. "But there was no time for pessimism, and the hard work ahead didn't scare me." At SMC, two weeks after her "two weeks to live," she pleaded to a doctor for a Keytruda prescription. But the doctor would not budge in her refusal. "My temper now getting the best of me, I snarled: 'So, what you're telling me is that you are afraid the Keytruda might kill me before the cancer you know will kill me? Is that the argument? Am I clear on that?' But please, please, just give me a f****** chance to fail. Please don't make the choice for me." The doctor relented. On Aug. 29, 2019, Gina received her first Keytruda infusion. It would be a 30-minute process every three weeks. Two days later, she wrote that her fever subsided. Her lung opened up 15 days later, creating movement in her body, near her rib cage, that was frightening at first. By the second infusion, she was sitting up on her own. She would continue to get stronger, building back every muscle in her body. By late September, Gina was using a walker in her parents' driveway. On Halloween, at her fourth Keytruda infusion at the Walker Cancer Center, Gina saw a nurse that she hadn't seen in over a month. Her book recounts the nurse's reaction: "I watched all the color drain from her face, and she dropped to her knees as she grabbed the cross around her neck. She began to sob right there on the floor. I ran over to comfort her, and she still looked at me as if I were a ghost." Gina believes she could have been given Keytruda on day one, sparing her body the indignity of wasting away. It would have also voided a $2 million ICU stay, she said. Despite being on Medicaid, Gina said she and Seth acquired about $200,000 in medical debt, noting, "living against medical advice isn't covered by Medicaid." They deployed their credit cards, sought financial help from her parents and a GoFundMe drive raised $15,000. "Nobody fights, especially not on Medicaid, because they expect you can't." No cancer, no naïvety Gina's most recent medical appointment reflected being 5 1/2 years cancer free. She is also free from her naïvety relating to medical care. "I think when you see a movie about a severe illness, there's a kind, compassionate, dedicated doctor cheering on the patient, staying up nights to figure out a way, a solution, a plan. I kinda expected that. I miss that naive me. And the patient is stoic, brave, suffering beautifully and angelically. Almost from the day of my diagnosis, I thought of that patient, the Hallmark Heroine. The thing about that woman? She always dies at the end, and people sob because it was so unfair." But that wasn't her fate, or in her nature. "I'd already had 46 years of being cynical, sarcastic and a bit of a jokester. And cancer didn't change that, because I refused to let it own me. To take over, to take away my ability to make fun of any and everything. They say a positive attitude is super beneficial in cancer, but I hope I have shattered that belief." Being "afraid of the world" was also a factor in Gina's cancer battle. "That made it easier to deal with, in a way. It was just another thing to be scared of. I was equally as afraid of going to the hospital, as I was of dying. It absolutely 100 percent saved my life. Without doubt or hesitation. Anxiety teaches you to look for the danger, seek all the exits, and always be prepared to flee. But perhaps above all, avoid situations that feel terrifying. Everything after February 15, 2019 felt out of control, and terrifying. No one in the medical world would have conversations anymore, they only talked at me." The thing about anxiety with PTSD, Gina explained, is that one can become very calm in chaos. "You think clear, sharp and exact. Stillness and boredom are terrifying, but the world blowing up clears the mind. And I think that's why I was able to spot flaws in my treatment plans and question the motivations for them that were nonsensical to me." A key pep talk Despite the medical professionals who "only talked at" Gina and recalled in her book, she also highlighted in her book a few individuals that gave her hope. One was a "Dr. Lee" who was doing a rotation as a hospitalist at SMC, while doing his actual residency at Roswell Park Comprehensive Cancer Center in Buffalo. He now works in Texas. "Dr. Lee was my magic. It's like he came in at the beginning with the best pre-game pep talk, and I followed it the rest of my journey. He was young and didn't have the ego or entitlement I've seen in so many other oncologists I encountered. He was enthusiastic about killing cancer. Stoked. Raring to go. Running into work to kill some cancer!" Gina said that he was also the first and last doctor to root for her. "Which likely sounds odd. But the doctors who saw me get better weren't impressed. It wasn't remarkable to them. They just thought I'd die." The biggest gaping wound Gina said she encountered in oncology was the lack of "heart" she saw in it. "The point is, if there were more Dr. Lee's, I honestly believe more people would survive. Caring spills over into treatment plans, into feeling valued, into a bond of trust, and helps avert not distrusting the doctors, the medicine, the conspiracies." Last month, Gina sent Dr. Lee a copy of her book with a note inside. "And now I feel a bit lighter. It was, in some way, vital for me to let him know how deeply he mattered, that I didn't die, and the part he played in that. And how many fans he has out there in the world now." Helping others As an advocate, Gina said she is contacted nearly every day by people who become familiar with her story. "I'm absolutely thrilled others find something of merit in the book. I didn't want to publish it. It was never my intent. But I felt a deep sense of survivor's guilt, and also I had seen and heard things that might help others avoid some of the unnecessary suffering I endured." Gina said that doctors still regard her as a Stage 4 cancer patient. "The reason is, is that somewhere in my body could be invisible, undetectable, latent cancer cells waiting to come back. The problem with that is that everybody has that. You do, he does," she said, pointing to Seth. I probably don't, because that Keytruda is bad ass!" Her situation is an issue each time she goes to a doctor, "From people being surprised, to the question of whether or not my being screened for other cancers is necessary because, I'm dying." She then laughed, and with well-earned sarcasm added, "I'm always 'dying.' Like, damn! I can't get a break."
Forbes
19 minutes ago
- Forbes
The Benefits And Drawbacks Of RFK Jr.'s New COVID Vaccine Recommendations
SAVANNAH, GA - DECEMBER 15: A nurse shows off a vial of the Pfizer-BioNTech COVID-19 vaccine ... More outside of the Chatham County Health Department on December 15, 2020 in Savannah, Georgia. (Photo by) RFK Jr. and the HHS will no longer recommend annual COVID-19 vaccines for healthy pregnant women and young adults, according to a video announcement posted on X May 27 by Secretary of Health and Human Services Robert F. Kennedy Jr. A few days later, the CDC took a slightly different stance and stated that children between the ages of 6 months and 17 years may get the COVID-19 vaccine through shared decision-making between parents and healthcare providers. The CDC also updated the adult immunization schedule to say there is 'no guidance' on use for pregnancy. These decisions have sparked much debate among public health experts, policymakers and government officials. Here are the pros and cons of such a policy shift. As Kennedy cited in his video announcement, the U.S. seems to be aligning its vaccine policy with other countries such as the U.K. and Australia that have stopped recommending routine COVID-19 vaccines for young healthy adults. In addition, according to the new recommendations, the focus of vaccinations will largely be on high-risk populations, namely those who are 65 years of age and older as well as younger individuals with at least one medical condition that puts them at high risk for COVID-19. This could allow resources and attention to be redirected to the populations that need the vaccine most. The new recommendations also demand evidence in answering important questions the public deserves to know. For younger healthy American adults, getting approval for the vaccine will require placebo-controlled trials to show a benefit for that particular population. As an example, does a healthy 31-year-old male with no medical problems need to get a COVID-19 booster every single year, even after having received several COVID-19 boosters in the past? These are the types of questions that all Americans would like to and deserve to know with respect to COVID vaccinations. On the flip side, the new recommendations have many public health experts concerned. Pregnant healthy females could be barred from getting the COVID-19 vaccine, since the CDC has failed to provide guidance on the issue. Without a strong recommendation from the CDC, many pregnant patients could face real barriers from insurance companies to cover the vaccine, according to The New York Times. Pregnant women are at high risk for COVID infection and complications because pregnancy results in a weakened immune system. As Dr. Steven Fleischman, President of the American College of Obstetricians and Gynecologists states, 'The science has not changed. It is very clear that COVID infection during pregnancy can be catastrophic and lead to major disability.' The new recommendations could harm vulnerable populations. In addition to potential decreased vaccination rates and adverse outcomes for pregnant females, children could also suffer. When pregnant females get vaccinated against COVID-19 in the third trimester, they are able to pass along antibodies and protection to their infants, who have not developed mature immune systems. If pregnant females do not get vaccinated, infants will lack these antibodies and could then go on to develop severe complications from the virus should they get infected. Finally, the new recommendations could limit access to the vaccine to those that want it. Private insurance companies usually require FDA approval and CDC recommendations to cover the vaccine as part of health insurance. The current CDC recommendations simply state young children may get the vaccine with shared-decision making, not outright stating that they should get the vaccine. In addition, the CDC falls short in explicitly recommending the vaccine for pregnant females. This could prevent private insurance companies from fully covering the vaccine. Ultimately, this may mean some pregnant women and those that cannot afford the vaccine may not have access to it. The new recommendations for the COVID-19 vaccine for children and pregnant females was made without the customary use of independent advisors, and could have important implications for public health. While aligning with international practices, the move could significantly limit the amount of vaccines available for millions of Americans.
CNN
21 minutes ago
- CNN
New research presents promising findings on colorectal cancer treatment and prevention
Colorectal cancer is the second most common cause of cancer deaths in the United States, according to the American Cancer Society. This year, the organization estimates that more than 150,000 Americans will be diagnosed with it and nearly 53,000 will die from it. New studies presented at the annual meeting of the American Society of Clinical Oncology, or ASCO, in the last few days offer promising findings for both pharmaceutical and lifestyle interventions, including the impact of diet and exercise. Diagnoses of colorectal cancer have been decreasing overall for decades, the American Cancer Society says, thanks in large part to better screening. But case rates are rising among younger adults, and research estimates that colorectal cancer will become the leading cause of cancer death among adults ages 20 to 49 by 2030. Earlier research has suggested that regular exercise can improve survival rates for colorectal cancer patients, and a new study – published in the New England Journal of Medicine and presented at the ASCO conference on Sunday – confirmed those findings with robust clinical trial data. Between 2009 and 2024, researchers followed nearly 900 colon cancer patients who had completed chemotherapy – half of whom received an informational booklet that encouraged them to adopt a healthy lifestyle with good nutrition and exercise the other half of whom were also matched with a physical activity consultant for three years. They found that there was a 28% reduction in the risk of recurrence or new cancer for patients on the exercise program, with a five-year disease-free survival rate of 80% for the group with an exercise consultant compared with 74% for the group who just received the booklet. In other words, the exercise program was found to prevent 1 out of every 16 patients from developing recurrent or new cancer. 'That magnitude is comparable to – and in many cases exceeds – the magnitude of benefit offered by a lot of our very good standard cancer drugs,' said Dr. Christopher Booth, a professor of oncology with Queen's University and co-author of the new study. 'Exercise really should be considered an essential component of treatment of colon cancer.' Work is still being done to understand why exercise can help reduce the risk of cancer, but experts say that it may have something to do with the ways exercise helps reduce inflammation in the body. Another new study presented at the ASCO conference on Sunday found that anti-inflammatory diets also helped improve survival rates for people with stage 3 colon cancer. Patients who consumed more anti-inflammatory diets – including coffee, tea and vegetables such as leafy greens – and engaged in higher levels of physical activity had a 63% lower risk of death compared to patients who consumed the most inflammatory diets – including things like red meat, processed meat, refined grains and sugar-sweetened beverages – and engaged in lower levels of physical activity, the study found. 'Actively, as a field, we're learning about the role of the immune system in cancer development, and inflammation is an immune response,' said Dr. Sara Char, a clinical fellow in Hematology and Oncology at Dana-Farber Cancer Institute and lead author of the study, and the rise of colorectal cancer cases in younger people suggests it's a critical piece of the puzzle. 'When we look at the incidence of colon cancer in younger individuals … that really suggests to us that there is something in the environment – either in the foods we eat, our lifestyles, the chemicals that could be in our foods, all sorts of different things – that are outside of just genetics alone that could be driving these rates,' she said. 'So it is incredibly important for us, as a field, to be thinking about how our diet and lifestyle impacts not just our risk of developing this cancer, but then how people fare after it.' Both Booth and Char said that colorectal cancer patients are often seeking ways to proactively manage their risk. 'I think that's it's very empowering for patients,' Booth said. 'It's also achievable for patients. This is a commitment, but it's something that patients can achieve.' In his study, an 'exercise prescription' was developed based on each individual's starting point. Most people were able to reach their target increase if they went for a brisk walk for about an hour three or four days per week, Booth said. Lifestyle interventions like exercise and diet are also 'sustainable for health systems,' he said, but it's key that the system helps support patients in accessing the resources needed for behavioral interventions. Another new study showed promising results that might represent a new standard-of-care for certain patients with advanced colon cancer. On Friday, drugmaker Pfizer presented data on a colorectal cancer drug, Braftovi, used in combination with a standard chemotherapy and an antibody drug. During the trial, the drug combo was shown to double the length of time patients with an aggressive form of colorectal cancer lived with treatment: an average of 30 months compared with 15 months using currently available treatments. Braftovi targets a mutation in a specific protein that can lead to abnormal cell growth, and it's already approved by the US Food and Drug Administration to treat some forms of cancer. The study, which was funded by Pfizer, published Friday in the New England Journal of Medicine. 'It's a targeted cancer therapy that really depends on knowing what's driving patients' cancer,' Pfizer CEO Dr. Albert Bourla told CNN. These targeted therapies are one of the biggest advancements in cancer treatment over the past two decades, he said, and it's easy to diagnose whether cancer patients have the specific mutation that Braftovi can treat. The latest data on treatment for colorectal cancer a 'very, very important finding,' Bourla said, and the drugmaker plans to seek additional approval to add the new indication to the drug's label.
